Clinical Trials on Neoplasm, Residual in United Kingdom
Total 49406 results
-
University of LeicesterActive, not recruitingCancerUnited Kingdom
-
King's College Hospital NHS TrustRecruiting
-
Wuerzburg University HospitalRoyal Marsden NHS Foundation TrustCompletedPain | Neoplasm Metastasis | Neoplastic Processes | Neoplasm, Residual | Neoplasm Recurrence, LocalSwitzerland, Netherlands, Germany, United Kingdom
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
University of BathUniversity of Southampton; Royal United Hospitals Bath NHS Foundation Trust; Great...CompletedChronic Lymphocytic Leukemia | Minimal Residual DiseaseUnited Kingdom
-
M.D. Anderson Cancer CenterSuspended
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnAcute Myeloid Leukemia | Minimal Residual Disease NegativityUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of Maryland, BaltimoreActive, not recruitingMixed Phenotype Acute Leukemia (MPAL) | Measurable Residual Disease (MRD)United States
-
Abramson Cancer Center at Penn MedicineRecruitingBreast CancerUnited States
-
Medicontur Medical Engineering LtdMedevise ConsultingRecruitingRefractive Errors | Presbyopia | Residual AstigmatismBelgium, France, Spain, United Kingdom
-
Lumicell, Inc.National Cancer Institute (NCI)Completed
-
EnteromeCompletedColorectal CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterBellicum Pharmaceuticals, Inc.Not yet recruitingColorectal Cancer | Minimal Residual DiseaseUnited States
-
M.D. Anderson Cancer CenterTaihoRecruitingColorectal CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Cancer | Colon CancerUnited States
-
AmgenTerminatedMyelodysplastic Syndrome | Relapsed/Refractory AML | Minimal Residual Disease Positive AMLUnited States, Canada, Germany, Netherlands
-
Hoffmann-La RocheNSABP Foundation Inc; German Breast GroupActive, not recruitingBreast CancerUnited States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
-
Washington University School of MedicineTaiho Oncology, Inc.RecruitingMyelodysplastic SyndromesUnited States
-
Personalis Inc.RecruitingMinimal Residual Disease | TNBC - Triple-Negative Breast CancerUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Memorial Sloan Kettering Cancer CenterPfizerWithdrawnAcute Myeloid Leukemia (AML) | Minimal Residual DiseaseUnited States
-
UNC Lineberger Comprehensive Cancer CenterActive, not recruitingLeukemia, Myeloid, Acute | Minimal Residual DiseaseUnited States
-
Jonsson Comprehensive Cancer CenterStemline Therapeutics, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
Roswell Park Cancer InstituteRecruitingColorectal Cancer | Metastatic Unresectable Sarcoma | Metastatic Malignant Neoplasm in the Lung | Resectable Sarcoma | Metastatic Soft Tissue Sarcoma | Metastatic Bone SarcomaUnited States
-
University of WashingtonPfizerRecruitingAcute Myeloid LeukemiaUnited States
-
University of FloridaCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, MyeloidUnited States
-
Exact Sciences CorporationNSABP Foundation IncRecruitingColorectal CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States
-
University of California, IrvineNatera, Inc.; Taiho Pharmaceutical Co., Ltd.RecruitingColorectal Cancer | Colon AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Stand Up To CancerActive, not recruitingBreast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual CancerUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
University of PennsylvaniaTerminatedLeukemia, Acute LymphoblasticUnited States
-
M.D. Anderson Cancer CenterBreakThrough TherapeuticsCompletedChronic Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
Boston Medical CenterCompleted
-
Masonic Cancer Center, University of MinnesotaWithdrawnAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
University of RochesterRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
Amgen Research (Munich) GmbHCompletedB-cell Acute Lymphoblastic LeukemiaAustria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
NorthShore University HealthSystemTerminatedPostoperative Residual Neuromuscular BlockadeUnited States
-
Vanderbilt-Ingram Cancer CenterCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyRecruitingAcute Lymphoblastic Leukemia | B-Cell Lymphoblastic LeukemiaUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDiurnal Residual Limb Fluid Volume FluctuationUnited States
-
University of Illinois at ChicagoRecruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Mayo ClinicRecruitingBreast Cancer | ResidualUnited States
-
Medical College of WisconsinRecruiting